Warhound, a new company from Ben Lamm and Palmer Luckey, has come out of stealth with $200M to genetically engineer dogs for military and law enforcement customers, and to equip them with gear from Anduril.
That is nearly everything the announcement gives us. The company is tied to two founders with defense-adjacent track records: Luckey is best known for founding Anduril, the defense contractor whose hardware appears in the pitch, and Lamm is known for running biotech ventures. The source names no investors, no timeline, no target traits, and no customers. It also does not say what "engineer" means in practice, whether direct gene editing or something closer to selective breeding.
The distinction matters. Militaries and police forces already use working dogs, but those animals are bred and trained the conventional way. Warhound's pitch moves the intervention earlier, into the genome, and then adds a hardware layer on top. A $200M round at launch suggests investors see a long, expensive development path rather than a quick product.
The open questions are practical and ethical. Regulators have no settled playbook for genetically modified animals sold as security assets, and the buyers are agencies with their own procurement rules. Until Warhound says which traits it is targeting and what oversight it expects, the business is easier to describe than to evaluate.